| Name | GSK9311 |
|---|---|
| Synonyms |
Benzamide, N-[2,3-dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-N-ethyl-2-methoxy
GSK 9311;GSK-9311 BRPF1 bromodomain inhibitor GS9311 GSK 9311 hydrochloride GSK9311 >= (HPLC) |
| Description | GSK9311 is a potent inhibitor of the BRPF bromodomain with pIC50 values of 6.0 and 4.3 for BRPF1 and BRPF2, respectively. |
|---|---|
| Related Catalog | |
| Target |
IC50: 6.0 (BRPF1), 4.3 (BRPF2)[1] |
| In Vitro | GSK6853 is a potent (300 pM), soluble, cell active (20 nM), and highly selective inhibitor of the BRPF1 bromodomain, and demonstrates properties suitable for cellular and in vivo studies. GSK6853 is a less active analogue of GSK6853 in which the 5-amide is alkylated[1]. |
| References |
| Molecular Formula | C24H31N5O3 |
|---|---|
| Molecular Weight | 437.544 |